Please login to the form below

Not currently logged in
Email:
Password:

patient advocates

This page shows the latest patient advocates news and features for those working in and with pharma, biotech and healthcare.

CGRP migraine drugs need prior approval for use, recommends ICER

CGRP migraine drugs need prior approval for use, recommends ICER

At that meeting, panel members drawn from patient advocates, physicians, public and private payers, and drug manufacturers voted that evidence was adequate to demonstrate a net health benefit of the CGRP

Latest news

  • Shire teams up with Microsoft and EURORDIS for rare disease project Shire teams up with Microsoft and EURORDIS for rare disease project

    Will work to accelerate the time to diagnosis for children. Shire has formed a strategic alliance with Microsoft and the European rare diseases patient group organisation EURORDIS to accelerate the time ... In turn they will bring together a dedicated

  • Facing the new wave of biosimilars Facing the new wave of biosimilars

    GAfPA campaigns across Europe to ensure patient access to appropriate clinically approved therapies. ... GAfPA has and continues to work with the European Federation of Crohn’s and Colitis Associations to increase patient awareness about these

  • Snapchat arrives at scientific meetings Snapchat arrives at scientific meetings

    patient advocates of all ages.”.

  • NOR-SWITCH - the final piece in the biosimilar puzzle? NOR-SWITCH - the final piece in the biosimilar puzzle?

    But the Global Alliance for Patient Access (GAfPA) - a network of physicians and patient advocates that campaigns for patient access to appropriate clinical care and approved therapies - believes it is important ... notably in Barcelona in February 2016

  • Orphan drugs: Leading the way in patient-centricity Orphan drugs: Leading the way in patient-centricity

    Orphan drug companies collaborate with patient advocates for example to demonstrate the burden of the disease, add it to the policy agenda and help to incorporate the rare patients' benefit-risk ... Lessons in patient-centricity . Patient engagement is

More from news
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • How pharma can unlock the potential of influencer marketing How pharma can unlock the potential of influencer marketing

    Building a successful campaign around influencer marketing. By Beth Whitworth. In this digital age, where the patient is increasingly at the centre of our campaigns, influencer marketing feels like a natural ... The advocates have proven to be critical

  • Reaching the new influencers Reaching the new influencers

    We’re already living in a new world, and reaching its new influencers - whether these are payers, population health specialists or patient advocates - requires that leaders be fully engaged with it. ... It demands fluency not just with the science

  • Beyond caring: learning from the unsung advocates in cancer care

    What can we do for advocates? Increasing patient access to advocates has the potential to fundamentally change the cancer experience for patients and their families. ... However it’s obvious that the patient experience doesn’t stop here. Advocates

  • The gold standard of scientific evidence The gold standard of scientific evidence

    Traditionally, few RCTs would collect patient-reported outcomes, although that is beginning to change. ... Policymakers, industry, patient advocates and others should work together to develop new sources of high-quality real-world data.

  • Delivering real patient value Delivering real patient value

    We refer to this approach as Patient Value Planning. 1. Start with the patient. ... The meetings included 250 senior pharma executives, leading physicians, FDA representatives and patient advocates, underscoring the growing interest across the industry

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Intellus round up 2018

    The theme of the conference was ‘7 billion voices’, exploring how patient experiences, programs and health literacy can be improved through insights delivered by market researchers in the pharmaceutical industry. ... As part of the keynote speeches,

  • Clark Health Communications unveils new positioning

    often across internal functions. It also expresses feedback that CHC instinctively knows how to build successful collaborations with healthcare professionals, patient advocates, media and other stakeholders as a fundamental part of

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics